Marc Zandecki

Marc Zandecki

Auto-generated profile, based on publicly available information

Marc Zandecki

Haematology Laboratory, University Hospital of Angers, Angers, France

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2007 in International Journal of Laboratory Hematology
Verified
Journal Article
Closed access
PDF file
MZM. Zandecki
M. Zandecki
FGF. Genevieve
F. Genevieve
JGJ. Gerard
J. Gerard
AGA. Godon
A. Godon

9 January 2007 in International Journal of Laboratory Hematology
Verified
Journal Article
Closed access
PDF file
MZM. Zandecki
M. Zandecki
FGF. Genevieve
F. Genevieve
JGJ. Gerard
J. Gerard
AGA. Godon
A. Godon

1 June 2015 in Morphologie
Verified
Journal Article
Closed access
BRB. Ribourtout
B. Ribourtout
MZM. Zandecki
M. Zandecki

1 July 2015 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
NWNathalie Wauthoz
Nathalie Wauthoz
GBGuillaume Bastiat
Guillaume Bastiat
EMElodie Moysan
Elodie Moysan
ACAnna Cieślak
Anna Cieślak
KKKazuya Kondo
Kazuya Kondo
JBJean-Pierre Benoit
Jean-Pierre Benoit

11 March 2010 in Retrovirology
Verified
Journal Article
Open access
PDF file
LZLinda Zane
Linda Zane
DSDavid Sibon
David Sibon
LJLionel Jeannin
Lionel Jeannin
MZMarc Zandecki
Marc Zandecki
MDMarie-Hélène Delfau-Larue
Marie-Hélène Delfau-Larue
EWEric Wattel
Eric Wattel
Background: Adult T cell leukemia results from the malignant transformation of a CD4+ lymphoid clone carrying an integrated HTLV-1 provirus that has undergone several oncogenic events over a 30-60 year period of persistent clonal expansion. Both CD4+ and CD8+ lymphocytes are infected in vivo; their expansion relies on CD4+ cell cycling and on the prevention of CD8+ cell death. Cloned infected CD4+ but not CD8+ T cells from patients without malignancy also add up nuclear and mitotic defects typical of genetic instability related to theexpression of the virus-encoded oncogene tax. HTLV-1 expression is cancer-prone in vitro, but in vivo numerous selection forces act to maintain T cell homeostasis and are possibly involved in clonal selection. Results: Here we demonstrate that the HTLV-1 associated CD4+ preleukemic phenotype and the specific patterns of CD4+ and CD8+ clonal expansion are in vivo selected processes. By comparing the effects of recent (1 month) experimental infections performed in vitro and those observed in cloned T cells from patients infected for >6-26 years, we found that in chronically HTLV-1 infected individuals, HTLV-1 positive clones are selected for tax expression. In vivo, infected CD4+ cells are positively selected for cell cycling whereas infected CD8+ cells and uninfected CD4+ cells are negatively selected for the same processes. In contrast, the known HTLV-1-dependent prevention of CD8+ T cell death pertains to both in vivo and in vitro infected cells. Conclusions: Therefore, virus-cell interactions alone are not sufficient to initiate early leukemogenesis in vivo.

6 September 2013 in International Journal of Laboratory Hematology
Verified
Journal Article
Closed access
PDF file
PDP. Dubreuil
P. Dubreuil
MPM. Pihet
M. Pihet
SCS. Cau
S. Cau
SCS. Croquefer
S. Croquefer
PDP. A. Deguigne
P. A. Deguigne
MZM. Zandecki
M. Zandecki